Pneumococcal Conjugate Vaccines Turning the Tide on Inequity: A Retrospective Cohort Study of New Zealand Children Born 2006-2015

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Helen Petousis-HarrisJennifer Griffin

Abstract

Hospitalization rates for infectious diseases in New Zealand (NZ) children have increased since 1989. The highest burden is among Māori and Pacific children, and the most socioeconomically deprived. New Zealand introduced pneumococcal conjugate vaccine (PCV)7 in June 2008, PCV10 in 2011, and PCV13 in 2014. A retrospective cohort study of NZ children aged <6 years between 2006 and 2015 was performed using administrative databases. Demographics and hospitalizations were linked to evaluate the impact of the PCV vaccination program on cases of invasive pneumococcal disease (IPD), all-cause pneumonia (ACP), and otitis media (OM), defined by ICD-10-AM codes, and to explore the effect by ethnicity and deprivation. Between 2006 and 2015, there were 640 children hospitalized with IPD, 26589 for ACP, and 44545 for OM. IPD hospitalizations declined by 73% between 2005 and 2015 for children <6 years of age, whereas ACP and OM declined by 8% and 25%, respectively. The highest rates for all diseases were among Māori and Pacific children and those from high deprivation. However, the declines were highest among Māori and Pacific children and those from socioeconomically deprived areas. IPD hospitalizations declined by 79% and 67% for Māori and...Continue Reading

References

Oct 31, 2000·The Pediatric Infectious Disease Journal·M BakerD Lennon
May 6, 2004·International Journal of Pediatric Otorhinolaryngology·Louis VernacchioAllen A Mitchell
Jul 29, 2004·Social Science & Medicine·James Ted McDonald, Steven Kennedy
Jul 11, 2006·International Journal of Pediatric Otorhinolaryngology·J E PatersonP A Silva
Oct 15, 2011·Journal of Paediatrics and Child Health·Diana LennonTeuila Percival
Feb 14, 2012·The Pediatric Infectious Disease Journal·Sean P FitzwaterHope L Johnson
Aug 21, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·A HagermanC-A Siegrist
Jun 13, 2013·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Yi-Jen ChenCheng-Hsun Chiu
Dec 18, 2013·The Pediatric Infectious Disease Journal·Jennifer D LooCynthia G Whitney
Aug 28, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shalom Ben-ShimolRon Dagan
Mar 6, 2015·The Pediatric Infectious Disease Journal·Sharon Ovnat TamirTal Marom
Oct 16, 2015·Pediatrics·Annabelle de St MauriceNatasha B Halasa
Jan 21, 2016·The Journal of Pediatrics·Alfredo TagarroUNKNOWN Bacteremia in Children Observation Program (BACO) Group
Jul 20, 2016·The Pediatric Infectious Disease Journal·Alfredo TagarroUNKNOWN BACO Group
Dec 14, 2016·The Lancet Infectious Diseases·Anand ManoharanUNKNOWN Alliance for Surveillance of Invasive Pneumococci (ASIP) Study Group
May 10, 2017·International Journal of Pediatric Otorhinolaryngology·Tal MaromEphraim Eviatar
Aug 9, 2017·Pediatrics·Ravinder KaurMichael E Pichichero
Aug 15, 2017·International Journal of Pediatric Otorhinolaryngology·Ivo VojtekBernard Hoet

❮ Previous
Next ❯

Citations

Apr 5, 2019·Journal of Immigrant and Minority Health·Nadia A CharaniaNikki M Turner
Jan 11, 2020·Italian Journal of Pediatrics·Jithin ThomasLina Jankauskaite
Jul 18, 2020·The Pediatric Infectious Disease Journal·Namrata PrasadE Claire Newbern
Jan 13, 2022·Human Vaccines & Immunotherapeutics·Patricia IzurietaLamine Soumahoro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.